Research graph
References from Redox-responsive and liver-targeted nanoplatform for paclitaxel delivery toward hepatocellular carcinoma therapy. Local targets link to admitted publications; unresolved targets remain external evidence.
Association of indomethacin with phospholipids increases their potential application against colorectal cancer
10.1016/j.biopha.2025.118390 · 2025 · External reference
Glycyrrhetinic acid mediated drug delivery carriers for hepatocellular carcinoma therapy
10.1021/acs.molpharmaceut.5b00677 · 2016 · External reference
Stress-inducible gene Atf3 in the noncancer host cells contributes to chemotherapy-exacerbated breast cancer metastasis
10.1073/pnas.1700455114 · 2017 · External reference
Chemosensitizing micelles self-assembled from amphiphilic TPGS-indomethacin twin drug for significantly synergetic multidrug resistance reversal
10.1177/0885328220975177 · 2021 · External reference
Novel insights into paclitaxel's role on tumor-associated macrophages in enhancing PD-1 blockade in breast cancer treatment
10.1136/jitc-2024-008864 · 2024 · External reference
Neutralizing tumor-promoting chronic inflammation: a magic bullet?
10.1126/science.1232227 · 2013 · External reference
A ROS-responsive nanoprodrug-engineered phage biotherapy for precision treatment of multidrug-resistant Gram-negative bacterial pneumonia
10.1016/j.jconrel.2025.113708 · 2025 · External reference
Dual activatable self-assembled nanotheranostics for bioimaging and photodynamic therapy
10.1016/j.jconrel.2020.07.045 · 2020 · External reference
Immune crosstalk in cancer progression and metastatic spread: a complex conversation
10.1038/s41577-019-0271-z · 2020 · External reference
Triphenylphosphonium-modified mitochondria-targeted paclitaxel nanocrystals for overcoming multidrug resistance
2019 · External reference
A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance
10.1016/j.biomaterials.2011.06.066 · 2011 · External reference
Nanoparticle-assisted combination therapies for effective cancer treatment
10.4155/tde.10.13 · 2010 · External reference
Recent advances of cocktail chemotherapy by combination drug delivery systems
10.1016/j.addr.2015.10.022 · 2016 · External reference
Stimuli-responsive nanodrug self-assembled from amphiphilic drug-inhibitor conjugate for overcoming multidrug resistance in cancer treatment
10.7150/thno.36163 · 2019 · External reference
DNA origami as a carrier for circumvention of drug resistance
10.1021/ja304263n · 2012 · External reference
Nanomaterial-mediated lactate metabolism regulation for enhanced cancer immunotherapy
2026 · External reference
Regulating lactate metabolism and remodeling the tumor microenvironment via a bio-hybrid nanoplatform for enhanced tumor photo-immunotherapy
2026 · External reference
Van der waals force-driven indomethacin-ss-paclitaxel nanodrugs for reversing multidrug resistance and enhancing NSCLC therapy
10.1016/j.ijpharm.2021.120691 · 2021 · External reference
Recent advances in redox-responsive polysaccharide-based nanostructures for cancer therapy
10.1016/j.carbpol.2026.124969 · 2026 · External reference
A branched small molecule-drug conjugate nanomedicine strategy for the targeted HCC chemotherapy
10.1016/j.ejmech.2021.114037 · 2022 · External reference
Bioisosteres of indomethacin as inhibitors of aldo-keto reductase 1C3 (AKR1C3)
10.1021/acsmedchemlett.8b00484 · 2019 · External reference
Reduction-responsive polymers for drug delivery in cancer therapy-is there anything new to discover?
10.1002/wnan.1678 · 2021 · External reference
Autocrine loop involving IL-6 family member LIF, LIF receptor, and STAT4 drives sustained fibroblast production of inflammatory mediators
10.1016/j.immuni.2017.01.004 · 2017 · External reference
Recent progress in nanocarrier-based drug delivery systems for antitumour metastasis
10.1016/j.ejmech.2023.115259 · 2023 · External reference
Preclinical lead optimization of small molecule inhibitors of TFCP2 (LSF) for the treatment of liver cancer
2026 · External reference
Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma
10.1080/10717544.2016.1225856 · 2017 · External reference
Combinational strategy for high-performance cancer chemotherapy
10.1016/j.biomaterials.2018.04.027 · 2018 · External reference
Modulation of MRP-1-Mediated Multidrug Resistance by Indomethacin Analogues
10.1021/jm0499099 · 2005 · External reference
10.1158/0008-5472.can-14-3525
10.1158/0008-5472.can-14-3525 · External reference
In vitro efficacy of paclitaxel-loaded dual-responsive shell cross-linked polymer nanoparticles having orthogonally degradable disulfide cross-linked corona and polyester core domains
10.1021/mp3005897 · 2013 · External reference
Pas de deux: control of anti-tumor immunity by cancer-associated inflammation
10.1016/j.immuni.2019.06.021 · 2019 · External reference
Redox responsive polymeric micelles of gellan gum/abietic acid for targeted delivery of ribociclib
10.1016/j.ijbiomac.2022.06.095 · 2022 · External reference
Ligand-mediated targeted drug delivery approaches against hepatocellular carcinoma
10.2174/1568009623666230503094346 · 2023 · External reference
Preparation of glycyrrhizic acid-modified BSA-nanoparticles and evaluation of their hepatic cellular distribution
10.1093/jpp/rgae019 · 2024 · External reference
Hepatocellular carcinoma downstaging for liver transplantation in the era of systemic combined therapy with anti‐VEGF/TKI and immunotherapy
10.1002/hep.32613 · 2022 · External reference
Glycyrrhizic acid modulates apoptosis through extrinsic/intrinsic pathways and inhibits protein kinase B- and extracellular signal-regulated kinase-mediated metastatic potential in hepatocellular carcinoma in vitro and in vivo
10.1142/s0192415x20500123 · 2020 · External reference
ABCB1 (MDR1) induction defines a common resistance mechanism in paclitaxel- and olaparib-resistant ovarian cancer cells
10.1038/bjc.2016.203 · 2016 · External reference
Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner
10.1158/0008-5472.can-14-0067 · 2014 · External reference
Self-assembling paclitaxel-mediated stimulation of tumor-associated macrophages for postoperative treatment of glioblastoma
2023 · External reference
Size‐controllable curcumin‐based metal‐organic framework‐integrated multifunctional hydrogel for wound healing through antibacterial and antioxidant properties
2026 · External reference
Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells
10.1021/bc200139n · 2011 · External reference
Disulfide-crosslinked reduction-responsive prodrug micelles for on-demand paclitaxel release
10.1016/j.jddst.2019.101168 · 2019 · External reference
Direct-space corrections enable fast and accurate lorentz-berthelot combination rule lennard-jones lattice summation
10.1021/acs.jctc.5b00726 · 2015 · External reference
Advances in combination therapy of lung cancer: rationales, delivery technologies and dosage regimens
10.1016/j.jconrel.2017.05.023 · 2017 · External reference
Glycyrrhetinic acid-cyclodextrin grafted pullulan nanoparticles loaded doxorubicin as a liver targeted delivery carrier
10.1016/j.ijbiomac.2022.07.182 · 2022 · External reference
Next-generation dynamic and combinatorial nanotherapies for liver cancer: mechanisms, current advances and future perspectives
2026 · External reference
Facile engineering indomethacin induced paclitaxel nanocrystal aggregates as carrier-free nanomedicine with improved synergetic antitumor activity
10.1021/acsami.8b22336 · 2019 · External reference
pH and reduction dual-responsive feather keratin - sodium alginate nanogels with high drug loading capacity for tumor-targeting DOX delivery
10.1016/j.polymertesting.2021.107375 · 2021 · External reference
Co-delivery of siBcl-2 and PTX with mitochondria-targeted functions to overcoming multidrug resistance
10.1016/j.ijpharm.2024.123970 · 2024 · External reference
O-GlcNAcylation regulates the stability of transferrin receptor (TFRC) to control the ferroptosis in hepatocellular carcinoma cells
10.1016/j.redox.2024.103182 · 2024 · External reference
Small-sized copolymeric nanoparticles for tumor penetration and intracellular drug release
10.1039/c9cc09716c · 2020 · External reference
Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy
10.7150/thno.42260 · 2021 · External reference
